Adisyn Coats a Full Chip Wafer With Graphene at Low Temperature — But Can a Pre-Revenue Micro-Cap Turn Lab Success Into Real Semiconductor Dollars?

Shares of Adisyn Ltd (AI1.AX) climbed to A$0.19, up 10%, as investors continued to digest the company's August 5 announcement that it deposited graphene across a full 200mm semiconductor wafer at below 300°C — scaling its low-temperature deposition process to a surface area roughly 300 times larger than its previous 1cm² test coupon . No new catalyst dropped today; this is follow-through buying from what is, by any measure, a significant lab milestone for a company trading on promise rather than profit.

• The Science Checked Out, and That Matters — The wafer was tested at 12 points across the surface, and every one came back with graphene confirmed, verified independently at the Hebrew University of Jerusalem . Independent validation gives the claim credibility with potential industry partners. But credibility is not a contract. From here, Adisyn chases a 300mm result while 200mm conversations with chipmakers progress, and the target remains a binding commercial deal with a global chipmaker .

• The 200mm Wafer Market Is Bigger Than People Think — There are more than a thousand chips in many new cars, and most came off a 200mm line. The format is also growing: SEMI has global 200mm capacity at record levels above 7.7 million wafers a month, with capacity heading past 8.2 million by 2030 . The broader 200mm wafer market was valued at $15.4 billion in 2025 and is forecast to reach $22.1 billion by 2034 . That is a large addressable market — but Adisyn first needs repeatable, production-grade films before any of it converts to revenue.

• The Numbers Tell a Pre-Revenue Story — In the last 12 months, Adisyn had revenue of just A$3.58 million and A$11.50 million in losses . The company holds A$4.73 million in cash , supplemented by institutional support from a A$14 million placement earlier this year . Both the semiconductor and defence programs remain pre-revenue, with further milestones required before commercial contracts can follow .

• Next Steps Will Determine Whether This Is Real — Investors will want to see whether the process can be repeated reliably and scaled in a way chipmakers could actually use; Adisyn is now targeting tier-1 players such as TSMC, Samsung, and Intel . The stock has roughly tripled from A$0.065 in April. At current prices, the market is paying for potential, not production. The gap between coating a wafer in a lab and licensing that process to a foundry remains the make-or-break risk.